Related Experiment Video
Updated: Mar 22, 2026

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Published on: October 7, 2017
The Benefits and Challenges of Preconsent in a Multisite, Pediatric Sickle Cell Intervention Trial
Mark Nimmer1, Jason Czachor2, Laura Turner3
1Pediatric Emergency Medicine, Medical College of Wisconsin, and the Children's Research Institute, Milwaukee, Wisconsin.
Abstract:
Enrollment of patients in sickle cell intervention trials has been challenging due to difficulty in obtaining consent from a legal guardian and lack of collaboration between emergency medicine and hematology. We utilized education and preconsent in a pediatric multisite sickle cell intervention trial to overcome these challenges. Overall, 48 patients were enrolled after being preconsented. Variable Institutional Review Board policies related to preconsent validity and its allowable duration decreased the advantages of preconsent at some sites. The utility of preconsent for future intervention trials largely depends on local Institutional Review Board policies. Preeducation may also benefit the consent process, regardless of site differences.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Clinical Trials: Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion
Clinical Trials
There are four phases in a clinical trial. A phase one...